title: Preoperative prophylactic OKT3 vs RATG. A randomized clinical study in heart transplant patients.
authors.affiliation: Clinica Medica II, IRCCS S. Matteo- Università di Pavia, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Ippoliti
authors.forename: M
authors.initials: M
authors.lastname: Negri
authors.forename: P
authors.initials: P
authors.lastname: Abelli
authors.forename: B
authors.initials: B
authors.lastname: Rovati
authors.forename: L
authors.initials: L
authors.lastname: Di Franco
authors.forename: P
authors.initials: P
authors.lastname: Grossi
authors.forename: L
authors.initials: L
authors.lastname: Minoli
authors.forename: E
authors.initials: E
authors.lastname: Ascari
authors.forename: M
authors.initials: M
authors.lastname: Viganó
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D005260:Female; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D016853:Muromonab-CD3; D016176:T-Lymphocyte Subsets / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3